Cue Biopharma
48 hedge funds and large institutions have $6.66M invested in Cue Biopharma in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $13M → $6.66M (-$6.32M)
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.35M | |
| 2 | +$735K | |
| 3 | +$250K | |
| 4 |
AWM
Angeles Wealth Management
Santa Monica,
California
|
+$116K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$57.2K |
Top Sellers
| 1 | -$93.3K | |
| 2 | -$71.6K | |
| 3 | -$61.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$28.4K |
| 5 |
NL
Navalign LLC
Encino,
California
|
-$18K |
